Tandem Diabetes Care, Inc. Accounts Receivable, before Allowance for Credit Loss
Tandem Diabetes Care, Inc. (TNDM) had Accounts Receivable, before Allowance for Credit Loss of $169.96 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AccountsReceivableGross · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, before Allowance for Credit Loss $169.96M.
- 2026-03-31: Accounts Receivable, before Allowance for Credit Loss $147.58M.
- 2025-12-31: Accounts Receivable, before Allowance for Credit Loss $173.88M.
- 2025-09-30: Accounts Receivable, before Allowance for Credit Loss $133.50M.
| Period end | Accounts Receivable, before Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $169.96M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $147.58M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $173.88M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $133.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $134.54M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $133.69M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $121.84M 10-K · filed 2026-02-19 |
| 2024-09-30 | $113.25M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $103.34M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $97.89M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $110.45M 10-K · filed 2025-02-26 |
| 2023-09-30 | $105.67M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $103.56M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $95.86M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $119.04M 10-K · filed 2024-02-21 |
| 2022-09-30 | $117.08M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $108.36M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $98.48M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $114.97M 10-K · filed 2023-02-22 |
| 2021-09-30 | $91.26M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $83.89M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $77.23M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $86.05M 10-K · filed 2022-02-22 |
| 2020-09-30 | $55.57M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $48.17M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $57.35M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $49.89M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |